Literature DB >> 25323016

Can anti-AQP4 antibody damage the blood-brain barrier?

Miho Akaza1, Keiko Tanaka, Masami Tanaka, Teruhiko Sekiguchi, Tamako Misawa, Kazutaka Nishina, Izumi Kawachi, Masatoyo Nishizawa, Hidehiro Mizusawa, Takanori Yokota.   

Abstract

BACKGROUND: Aquaporin 4 (AQP4) is a water-channel protein predominantly expressed in astrocyte end feet that make up the blood-brain barrier (BBB). Recently, anti-AQP4 antibody has been identified as a specific biomarker of neuromyelitis optica (NMO). However, whether anti-AQP4 antibodies damage the BBB is unclear.
METHODS: We evaluated BBB damage in patients with NMO and multiple sclerosis by measuring albumin leakage (AL) and studied its correlation with anti-AQP4 antibody.
RESULTS: No obvious difference in AL was observed between patients with and without anti-AQP4 antibodies. In the multivariate analysis, anti-AQP4 antibody was not associated with BBB damage. Of the anti-AQP4-positive patients, 58.0% had normal AL values, and the degree of BBB damage was unrelated to the anti-AQP4 antibody titer. In addition, 41.9% of anti-AQP4-positive patients showed no gadolinium enhancement of the MRI.
CONCLUSION: These results indicate that the presence of anti-AQP4 antibody alone in plasma is insufficient to disrupt the BBB.
© 2014 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25323016     DOI: 10.1159/000360619

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  2 in total

1.  Blood Brain Barrier Permeability Could Be a Biomarker to Predict Severity of Neuromyelitis Optica Spectrum Disorders: A Retrospective Analysis.

Authors:  Ying Wang; Mingqin Zhu; Caiyun Liu; Jinming Han; Wenjuan Lang; Yang Gao; Chao Lu; Shuang Wang; Shuai Hou; Nannan Zheng; Dong Wang; Yang Chen; Yu Zhang; Hong-Liang Zhang; Jie Zhu
Journal:  Front Neurol       Date:  2018-08-07       Impact factor: 4.003

Review 2.  Pathogenesis of autoimmune demyelination: from multiple sclerosis to neuromyelitis optica spectrum disorders and myelin oligodendrocyte glycoprotein antibody-associated disease.

Authors:  Joseph A Lopez; Martina Denkova; Sudarshini Ramanathan; Russell C Dale; Fabienne Brilot
Journal:  Clin Transl Immunology       Date:  2021-07-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.